With the de-scheduling of cannabinoids from the Canadian Controlled Drug Substance Act expected to occur during the second half of 2018, Cardiol … Read More
The post Cardiol Therapeutics Closes CDN$10.5 Million Private Placement appeared first on Dagga Magazine.